Grace

Company Overview

Snapshot

Founded in January 2025 by David Futorian, Grace operates with 1–10 employees. The company is currently in stealth mode, focusing on R&D in the drug discovery sector.

Business overview

Grace is a Health Tech & Life Sciences company leveraging Artificial Intelligence to address challenges in drug development. The company's core technology focuses on AI-driven drug discovery, serving the pharmaceutical and medical biotechnology sectors. Grace operates within the broader Digital Healthcare and Artificial Intelligence categories.

Strategic signal

In January 2025, former Verbit CEO Tom Livne launched Grace, signaling a significant new venture in the AI-driven drug discovery space. This move indicates a strategic focus on applying advanced AI to tackle complex challenges within pharmaceutical development, potentially attracting further investment and talent to the sector.

Company Intelligence Q&A

When was Grace founded?

Grace was founded in January 2025.

Who are the co-founders of Grace?

David Futorian is a co-founder of Grace. Tom Livne also serves as Co-founder & CEO, and Shay Liraz is a co-founder.

What is Grace's primary focus?

Grace focuses on discovering drugs using Artificial Intelligence, aiming to tackle challenges in drug development.

What is Grace's current product development stage?

Grace is currently in the R&D stage of product development, as of January 2025, focusing on leveraging AI for drug discovery.

What significant leadership news was announced regarding Grace?

In January 2025, it was announced that Tom Livne, former CEO of Verbit, launched Grace as a new startup.